Lewis Karen (CIK 1814304) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-01-30). Recent activity: Sell APLS (364 shares), Sell APLS (1,751 shares), Sell APLS (1,241 shares), Buy APLS (28,508 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief People Officer | Sell | 364 | $10,745 |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief People Officer | Sell | 1,751 | $53,283 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief People Officer | Sell | 1,241 | $37,180 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief People Officer | Buy | 28,508 | $0 |
Source: SEC Form 4 filings · as of 2025-01-30